Sebikan Tablet 5/40 mg
Olmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Shintax Pharmaceutical Co., Ltd.
MFDS item code 202000233 · Approved 2020.01.15
This product's status changed to Expired on 2025.01.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
Amlodipine or olmesartan medoxomil is used for the treatment of essential hypertension and helps effectively lower blood pressure when monotherapy does not adequately control it. This can reduce the risk of cardiovascular complications arising from hypertension. This medication works by dilating blood vessels or regulating blood pressure, improving health. Therefore, it is used to achieve appropriate blood pressure control in patients with essential hypertension.
Administer 1 tablet once daily with water, regardless of meals. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, switching directly to this drug may be considered if blood pressure is not controlled with monotherapy using either individual component. The maximum dose of this drug is 10/40 milligrams. Since the maximum blood pressure-lowering effect occurs within 2 weeks of administration, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows: - 5/20 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: Administer to patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: Administer to patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: Administer to patients whose blood pressure is not adequately controlled with 5/40 milligrams. ∘Patients with renal impairment: This drug has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil in patients with mild or moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily, and use of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild or moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. Patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics should be closely monitored for blood pressure and renal function. This drug should not be administered to patients with severe hepatic impairment. (See Precautions for Use, section 2, Do not administer to the following patients.) ∘Older adults: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. In older adults, blood pressure should be monitored closely and more frequently.
The safety and efficacy of this drug have not been established in pediatric patients younger than 18 years.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to the active ingredients or similar classes of drugs, pregnant women, nursing mothers, those with severe liver impairment or certain heart diseases, patients undergoing kidney dialysis, patients in shock, and those with specific diabetes conditions should not take this medication. Patients with hypotension due to lack of fluids or salt may experience initial hypotensive symptoms upon taking the medication, so their condition should be carefully monitored, and appropriate treatment should be received if hypotension occurs. Rapid dilation of blood vessels may lead to hypotension, so special caution is required for patients with valvular heart disease. Patients with heart failure should use this medication cautiously, and patients with reduced kidney function may experience renal function changes, requiring careful monitoring. Patients with impaired liver function should also be cautious when taking this medication. This drug may cause various side effects such as dizziness, headache, hypotension, edema, dyspepsia, skin rash, etc., so any unusual symptoms should be discussed with a healthcare professional. Nursing mothers should be aware that this medication can be transmitted through breast milk and may affect infants, so it is advisable to discontinue breastfeeding or the medication. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been established. Elderly patients may have increased drug concentrations in the body due to reduced kidney and liver function, so dose adjustments and careful monitoring are necessary. In cases of overdose, hypotension and heart function decline may occur, necessitating immediate medical attention for proper treatment. This medication should be stored in a sealed container to avoid exposure to direct sunlight and moisture, and it should not be transferred to another container. During treatment with this medication, there may be interactions with certain drugs, so healthcare providers should be informed if other medications are being taken.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius.
Pale yellow round film-coated tablets
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Shintax Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.